Work

Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness Study

Year: 2009

Type: article

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2009.06.005

Authors: Jonathan M. Meyer, Joseph P. McEvoy, Vicki G. Davis, Donald C. Goff, Henry A. Nasrallah, Sonia M. Davis, John K. Hsiao, Marvin S. Swartz, T. Scott Stroup, Jeffrey A. Lieberman

Institutions: University of California San Diego, VA San Diego Healthcare System, Duke University, University of North Carolina at Chapel Hill, Harvard University, Massachusetts General Hospital, University of Cincinnati, IQVIA (United States), National Institutes of Health, National Institute of Mental Health, Duke Medical Center, Columbia University

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Center for Research Resources

Awards: G1121004391, G2755446375, G445903376, Duke University Center for Translational Research, Duke CTSI, CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES, New Treatment and Mechanisms in Schizophrenia

OpenAlex ID: W2081921819

FWCI: 6.803

Cites: 56

Cited by: 108

Related to: 10